BRAF and skin basal cell carcinoma: Our data also suggest that BCC patients with a STR somatic mutation in BRAF showed marked overexpression of “inflamed T-cell”-related genes with a FC of 6.1 (95% CI 3.8–9.6) compared to those who did not have a STR somatic mutation in BRAF with a FC of 2.3 (95% CI 1.6–3.4) (see the upper panel of Figure 13; ANOVA interaction p = 4.21 × 10−5).